1Stock1.com
Google
 
1Stock1 Home
Financial Ratios
Mutual Fund Investing Terms
Option Trading Terms 
Stock Investing Terms
Salix Pharmaceuticals, Ltd. (SLXP) Yearly Returns
     Year
  Beginning Price
  Ending Price
  Gain or Loss
  Percent Gain or Loss
2001
11.25
20.25
9.00
80.00%
2002
20.25
6.99
-13.26
-65.48%
2003
6.99
22.68
15.69
224.46%
2004
22.68
26.385*
3.705
16.34%
2005
17.59
17.58
-0.01
-0.06%
2006
17.58
12.17
-5.41
-30.77%
2007
12.17
7.88
-4.29
-35.25%
2008
7.88
8.83
0.95
12.06%
2009
8.83
25.39
16.56
187.54%
2010
25.39
46.96
21.57
84.95%
2011
46.96
47.85
0.89
1.90%
2012
47.85
40.47
-7.38
-15.42%
2013
40.47
89.94
49.47
122.24%
2014
89.94
114.94
25.00
27.80%
2015
114.94
173.00*
58.06
50.51%
*The 2004 ending price for Salix Pharmaceuticals has been adjusted for 3 for 2 stock split.
*In 2015, Valeant Pharmaceuticals (VRX) completed its acquisition of Salix Pharmaceuticals (SLXP) for $173 per share.
Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).
Disclaimer/Contact Us
Stock Performance Guide         
Yearly Stock Returns Index     
Back to Yearly Stock Returns Index
Articles
From
1stock1.com